Recrutement de participants aux études

Project Title: An Exploratory Study of Cannabis Use in People with Osteoarthritis

Study Investigators: Dr. Holly Mansell (Principal Investigator), Erin Yakiwchuk (Sub-Investigator), Dr. Jane Alcorn (Sub-Investigator), and Gabriela Louriero (Student) 

Research Host Institution: University of Saskatchewan, College of Pharmacy and Nutrition 

Study Aims: Osteoarthritis is a common condition, and it can affect how people are able to move and function, and their quality of life. There are treatments available to help manage osteoarthritis, but many people still have pain and are turning to alternative medications to help. The research investigators for this study want to learn more about using cannabis to manage osteoarthritis pain. 

Eligibility Criteria: 

• Patients over 18 years of age with osteoarthritis and

• Currently using any cannabis product(s) for osteoarthritis pain

Participation: The study will involve completing two surveys (totalling approximately 20 minutes in length) and collecting a self-administered blood sample to determine how much cannabis is in your blood. This blood sample can be taken at home and does not require visiting a laboratory. 

As compensation for your time, participants will receive a $20 gift card. 

For more participant information and to access the participant consent form, please  visit: https://redcap.link/cannabisinosteoarthritis

Confidentiality Protocol: Your personal information will remain private throughout the study. Once the study is complete, your name and identifying information will be removed from the study results.The Research Team will present the results of the study in an article and may present the results at a medical conference or publish them in a medical journal. The data presented in publications or at conferences will be pooled and deidentified so that you cannot identify the people who participated in the study. 

Contact Information: 
For any questions regarding this study, please contact:
(306) 966-1013 or email: cannabis.osteoarthritis.study@usask.ca

Recruitment Start Date: May 29, 2023 
Recruitment End Date: December 31, 2023

Objectifs de l'étude : L’Équipe de INGAUGE à l’Université du Manitoba, dirigé par Dre Roberta Woodgate, mène présentement une étude intitulée « Faire avancer les soins centrés sur le patient pour les jeunes personnes vivant avec de la douleur chronique ». L’étude a pour but de comprendre et préciser les expériences, les besoins, et priorités des jeunes personnes qui vivent avec la douleur chronique, et de cocréer et évaluer des produits d’application de connaissances basées sur l’art.

Admissibilité et participation : Nous cherchons présentement des jeunes personnes entre 12 et 34 ans qui vivent avec de la douleur chronique (récurrente ou persistante qui à duré au moins 3 mois) qui désirent participer à l’étude. Il s’agit de participation dans une entrevue individuelle (e.g., par Zoom), une activité de photographie, et la création de produits de recherche basées dans l’arts.  L’information partagé lors de l’étude sera privée et confidentielle (c'est-à-dire que personne à l’extérieur de l’équipe de recherche ne saura si vous avez participé et/ou ce que vous avez dit) et les résultats aideront à savoir comment appuyer les jeunes personnes qui vivent avec la douleur chronique.  

La participation à l’étude ne vous fera courir aucun risque et s’il y a des activités ou questions qui vous rendent inconfortable, vous pouvez terminer votre participation à l’étude à n’importe quel temps sans conséquences. Chaque étape ou activité de l’étude prendra environs une à deux heures de temps, et vous allez recevoir un honoraire (carte-cadeaux) pour vous remercier pour votre temps. L’étude est présentement en déroulement et durera jusqu’au milieu de l’année 2024. Les participants qui habitent n’importe-où au Canada sont bienvenue. 

Détails du contact : Si la participation à l’étude vous intéresse, ou si vous désirez recevoir plus d’information avant de décider de participer, s.v.p. contacter ingauge@umanitoba.ca ou 204-481-4994. Si vous envoyer un courriel, veuillez s.v.p. indiquer que vous êtes intéressé à l’étude portant sur la douleur chronique. 

Principal investigators: Debbie Feldman, PhD, Université de Montréal, Sasha Bernatsky, MD PhD, Université McGill, Linda Woodhouse, PhD, University of Alberta 

Project description and objectives: Our project, funded by the Canadian Initiative for Outcomes in Rheumatology Care (CIORA) of the Canadian Rheumatology Association focuses on the identification process by physiotherapists of newly affected patients with  inflammatory arthritis and the consequences of rapid referral of these patients to rheumatology care. The purpose of the focus groups is to explore how to facilitate appropriate referrals in rheumatology and optimize the care of a patient with inflammatory arthritis. The focus group will be composed of 4-8 patients and the main goal is to help optimize patient care in inflammatory arthritis. 

If you are interested in further details about this research, please contact Tatiana Rodriguez, Tatiana.orozco.rodriguez@gmail.com. 

Read the Invitation

Project Title: The safety and efficacy of genicular radiofrequency ablation for patients with persistent knee pain following total knee arthroplasty

Study Investigators: Dr. Robert Burnham, Dr. Ashley Smith, Dr. Taylor Burnham, and Dr. David Hart 

Research Host Institutions: Vivo Cura Health (Calgary, Alberta), the CAPRI clinic (Lacombe, Alberta), and the University of Calgary. 

Background: Unfortunately, 15-30% of people receiving total knee joint arthroplasty (TKA) continue to experience knee pain, reduced quality of life and functional impairment and have few available treatment options. Genicular radiofrequency ablation (GRFA) has been described, refined, and validated as an effective minimally invasive intervention to treat refractory knee osteoarthritis. It has not been thoroughly examined in people following TKA. 

Purpose of Study: To determine the safety and efficacy of GRFA in patients with failed TKA.

Eligibility Criteria: 

• > 50 years old

• 1+ years since total knee replacement

• At least 4/10 average knee pain intensity

• No response to conventional treatment

• Successful response to ‘freezing’ of the nerves around the knee

Participation Details: Participants will be enrolled in active or sham GRFA. Possible risks include bruising, swelling, as well as more uncommon complications such as infection, skin burns, and lower leg weakness, or numbness. Participants will be required to complete a series of questionnaires to evaluate pain, disability, function, and quality of life. These will be repeated again 6-months later. Participants will be followed for 12-months.

Confidentiality Protocols: All information collected about participants will be kept under strict confidentiality. 

Recruitment start and end dates: 
May 2022 - June 2024

Contact Information: 
Jennifer Laxshimalla, BSc. Clinical Research Coordinator Vivo Cura Health
(403) 265-3838 ext. 2100
research@vivocura.ca.